|
Status of the patients used in the study |
||||||||||||
| Patient |
Status |
RT (*) |
Weeks Amenhorrhea |
Year mother |
HTA (**) |
Proteinuria g/24 h |
Uterine Doppler (****) |
Oligoamnios |
Apgar 1 |
Apgar 5 |
SEX |
Birthweight in g (Percentile) |
|
|
||||||||||||
| 3008 |
Term (control) |
784 |
38+4 |
32 |
normal |
normal |
normal |
normal |
10 |
10 |
M |
3050 |
| 7497 |
Term (control) |
816 |
38+0 |
34 |
normal |
normal |
normal |
normal |
10 |
10 |
M |
3270 |
| 497 |
Term (control) |
817 |
40+5 |
35 |
normal |
normal |
normal |
normal |
10 |
10 |
M |
3040 |
| 3007 |
Term (control) |
818 |
38+4 |
43 |
normal |
normal |
normal |
normal |
10 |
10 |
M |
3430 |
| 3011 |
Term (control) |
819 |
38+0 |
37 |
normal |
normal |
normal |
normal |
10 |
10 |
M |
3710 |
| 3013 |
Term (control) |
820 |
39+4 |
42 |
normal |
normal |
normal |
normal |
10 |
10 |
F |
2740 |
| 3017 |
Term (control) |
821 |
38+5 |
41 |
normal |
normal |
normal |
normal |
10 |
10 |
F |
3110 |
| 3004 |
PE |
765 |
28+5 |
34 |
205/120 |
10,69 |
normal |
normal |
2 |
8 |
M |
830 |
| 3005 |
PE |
766 |
37+4 |
45 |
140/90 |
0,17 |
Unilateral |
normal |
10 |
10 |
F |
2930 |
| 225 |
PE |
807 |
27+0 |
24 |
145/90 |
2,7 |
normal |
normal |
9 |
10 |
M |
1080 |
| 242 |
PE |
867 |
33+1 |
26 |
150/95 |
5,36 |
normal |
normal |
8 |
10 |
M |
1960 |
| 3010 |
PE |
808 |
32+5 |
36 |
160/110 |
14,36 |
normal |
normal |
10 |
10 |
M |
1196 |
| 50 |
PE |
885 |
30+0 |
22 |
175/105 |
8,68 |
normal |
normal |
8 |
10 |
M |
1390 |
| 4003 |
PE+IUGR |
915 |
34+1 |
36 |
180/120 |
2,1 |
normal |
amniotic fluid in excess |
0 |
7 |
F |
1670 (< 5) |
| 3012 |
PE+IUGR |
770 |
34+1 |
37 |
140/90 |
6,98 |
normal |
unknown |
9 |
10 |
F |
1800 (between 5 and 10) |
| 3016 |
PE+IUGR |
772 |
28+0 |
37 |
160/100 |
nc |
bilateral |
Abnormal |
7 |
10 |
M |
780 (< 5) |
| 3003 |
vascular IUGR |
773 |
37+3 |
26 |
160/90 |
normal |
bilateral |
unknown |
10 |
10 |
M |
1890 (between 5 and 10) |
| 3021 |
vascular IUGR |
810 |
31+3 |
35 |
normal |
normal |
bilateral |
Abnormal |
7 |
10 |
M |
1380 (> 10 but ***) |
| 3022 |
vascular IUGR |
814 |
37+0 |
33 |
normal |
normal |
unknown |
Abnormal |
3 |
9 |
M |
2330 (between 5 and 10) |
|
* RT: reversed transcribed RNA sample ** HTA: Arterial Hypertension *** IUGR defined bya break in the intrauterine growth curve, a bilateral doppler associated with an absence of diastolic pressure **** Presence of a doppler signal in one or both the umbilical arteries | ||||||||||||
Vaiman et al. BMC Genomics 2005 6:111 doi:10.1186/1471-2164-6-111 |
||||||||||||